133 related articles for article (PubMed ID: 2084728)
1. [Blood MAO/DBH index and the results of the treatment of endogenous depression].
Puzyński S; Hauptmann M; Rode A; Kalinowski A; Bidzińska E; Beresewicz M; Bidziński A
Psychiatr Pol; 1990; 24(3):202-8. PubMed ID: 2084728
[TBL] [Abstract][Full Text] [Related]
2. Serum DBH and platelet MAO in patients with depressive disorders.
Honecker H; Fähndrich E; Coper H; Helmchen H
Pharmacopsychiatria; 1981 Jan; 14(1 Suppl):10-4. PubMed ID: 7248043
[TBL] [Abstract][Full Text] [Related]
3. [Determination of dopamine-beta-hydroxylase (DBH) and monoamine oxidase (MAO) activities in platelets and plasma in schizophrenic, maniac-depressive and neurotic patients].
Xavier Vieira R; Azevedo M; Polónio P; Manso C
Acta Med Port; 1986; 7(1):45-8. PubMed ID: 3728081
[No Abstract] [Full Text] [Related]
4. Dopamine-beta-hydroxylase, monoamine oxidase, and schizophrenia.
DeLisi LE; Wise CD; Potkin SG; Zalcman S; Phelps BH; Lovenberg W; Wyatt RJ
Biol Psychiatry; 1980 Dec; 15(6):895-907. PubMed ID: 7459411
[TBL] [Abstract][Full Text] [Related]
5. [MAO inhibitors and depressive disorders today].
Bonamy D; Olié JP; Lôo H
Encephale; 1983; 9(2):123-36. PubMed ID: 6641614
[TBL] [Abstract][Full Text] [Related]
6. Studies on biogenic amine metabolizing enzymes (DBH, COMT, MAO) and pathogenesis of affective illness. III. Platelet monoamine oxidase activity in endogenous depression.
Puzynski S; Hauptmann M; Zaluska M
Acta Psychiatr Scand; 1983 Feb; 67(2):101-8. PubMed ID: 6846038
[TBL] [Abstract][Full Text] [Related]
7. Association between high platelet MAO activity and response to MAO inhibitor in depressed bipolars: case reports.
Rihmer Z; Arató M; Bagdy G
Pharmacopsychiatria; 1983 Jul; 16(4):119-20. PubMed ID: 6634937
[TBL] [Abstract][Full Text] [Related]
8. [Significance of various enzymes of mediator metabolism for evaluation of depression and therapeutic prognosis].
Vertogradova OP; Misionzhinik EIu; Poliakov SE; Uzbekov MG
Zh Nevropatol Psikhiatr Im S S Korsakova; 1992; 92(1):99-103. PubMed ID: 1319664
[TBL] [Abstract][Full Text] [Related]
9. MAO, DBH and COMT: the effect of anxiety.
Mathew RJ; Ho BT; Kralik P; Taylor D; Claghorn JL
J Clin Psychiatry; 1980 Dec; 41(12 Pt 2):25-8. PubMed ID: 7440522
[TBL] [Abstract][Full Text] [Related]
10. Low platelet MAO activity in psychiatric patients and plasma factors: no evidence for inhibitory influences on MAO in the circulating platelet population.
Demisch L; Gebhart P; Kaczmarczyk P; von der Mühlen H; Bochnik HJ
Biol Psychiatry; 1981 Jan; 16(1):21-33. PubMed ID: 7225472
[TBL] [Abstract][Full Text] [Related]
11. [Blood platelet MAO activity in endogenous depressive syndrome].
Puzyński S; Hauptmann M; Załuska M
Psychiatr Pol; 1980; 14(6):575-80. PubMed ID: 7232599
[No Abstract] [Full Text] [Related]
12. Neurotransmitter-related enzymes in the major psychiatric disorders: II. MAO and DBH in schizophrenia.
Wyatt RJ; Murphy DL
Res Publ Assoc Res Nerv Ment Dis; 1975; 54():289-97. PubMed ID: 769116
[No Abstract] [Full Text] [Related]
13. Serum dopamine-beta-hydroxylase activity in depression and anxiety.
Friedman MJ; Stolk JM; Harris PQ; Cooper TB
Biol Psychiatry; 1984 Apr; 19(4):557-70. PubMed ID: 6733175
[TBL] [Abstract][Full Text] [Related]
14. The effect of isocarboxazid on platelet MAO activity.
Davidson J; White H
Biol Psychiatry; 1983 Sep; 18(9):1075-9. PubMed ID: 6640004
[No Abstract] [Full Text] [Related]
15. Peripheral markers of neurochemical effects among styrene-exposed workers.
Bergamaschi E; Mutti A; Cavazzini S; Vettori MV; Renzulli FS; Franchini I
Neurotoxicology; 1996; 17(3-4):753-9. PubMed ID: 9086498
[TBL] [Abstract][Full Text] [Related]
16. Clinical correlates of tricyclic antidepressant-mediated inhibition of platelet monoamine oxidase.
Sullivan JL; Zung WW; Stanfield CN; Cavenar JO
Biol Psychiatry; 1978 Jun; 13(3):399-407. PubMed ID: 667237
[TBL] [Abstract][Full Text] [Related]
17. The effects of testosterone on plasma and platelet monoamine oxidase (MAO) an plasma dopamine-beta-hydroxylase (DBH) activities in the male rhesus monkey.
Redmond DE; Baulu J; Murphy DL; Loriaux DL; Zeigler MG; Lake CR
Psychosom Med; 1976; 38(5):315-26. PubMed ID: 824661
[TBL] [Abstract][Full Text] [Related]
18. Use of dopamine-beta-hydroxylase-deficient mice to determine the role of norepinephrine in the mechanism of action of antidepressant drugs.
Cryan JF; Dalvi A; Jin SH; Hirsch BR; Lucki I; Thomas SA
J Pharmacol Exp Ther; 2001 Aug; 298(2):651-7. PubMed ID: 11454927
[TBL] [Abstract][Full Text] [Related]
19. Studies on biogenic amine metabolizing enzymes (DBH, COMT, MAO) and pathogenesis of affective illness. I. Plasma dopamine-beta-hydroxylase activity in endogenous depression.
Puzynski S; Rode A; Zaluska M
Acta Psychiatr Scand; 1983 Feb; 67(2):89-95. PubMed ID: 6846042
[TBL] [Abstract][Full Text] [Related]
20. Enzyme studies in tardive dyskinesia. II. Familial aspects.
Delisi LE; Jeste DV; Phelps BH; Wyatt RJ
J Clin Psychopharmacol; 1982 Oct; 2(5):315-7. PubMed ID: 7130433
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
